Sensor Validation Study - Quality Assurance

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

July 28, 2017

Primary Completion Date

August 7, 2018

Study Completion Date

September 7, 2018

Conditions
Respiratory Rate
Interventions
DEVICE

RespiraSense Respiratory Rate Monitor

RespiraSense device will be attached at the same time as the capnograph (gold standard) and both will measure simultaneously for one hour

Trial Locations (1)

PO6 3LY

Queen Alexandra Hospital, Portsmouth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PMD Solutions

INDUSTRY

NCT03306537 - Sensor Validation Study - Quality Assurance | Biotech Hunter | Biotech Hunter